Top Abstract Purchase Related
Home
>
Node
>
Subnode

Cerebrospinal fluid markers of prion diseases

Golańska, E.; Gresner, S.; Sieruta, M.; Liberski, P.ł

Neurologia i Neurochirurgia Polska 42(5): 441-450

2008

ISSN/ISBN: 0028-3843
PMID: 19105113
Document Number: 619946
There are no non-invasive tests allowing for definite premortem diagnosis of Creutzfeldt-Jakob disease (CJD). The paper presents the current knowledge about laboratory tests supporting CJD diagnosis. 14-3-3 protein in the cerebrospinal fluid is the only biochemical marker included in the diagnostic criteria for CJD approved by WHO. However, the test for 14-3-3 protein is useful only when considered in an appropriate clinical context, together with other diagnostic criteria. In the paper we also present current research in the use of other proteins detected in the cerebrospinal fluid (tau, S100b, neuron-specific enolase, transthyretin, and beta-amyloid1-42 as potential diagnostic markers. We discuss advantages and drawbacks of these markers.

Document emailed within 1 workday
Secure & encrypted payments

Tagami, T. 1970: Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern Nippon Ganka Gakkai Zasshi 74(9): 1129-1135
Sakaguchi, S. 2007: Physiological functions of prion protein and its roles in the pathogenesis of prion diseases Seikagaku. Journal of Japanese Biochemical Society 79(9): 843-852
Roelcke, U.; Heil, J. 1993: Fatty acids as markers of the blood-cerebrospinal fluid barrier function in man Functional Neurology 8(3): 189-192
Shi, Q.; Pu, C-qiang.; Wu, W-ping.; Huang, X-sheng.; Yu, S-yuan.; Tian, C-lin.; Cao, X-tang. 2009: The determination of medical reference values for tumor markers in cerebrospinal fluid Zhonghua Yi Xue Za Zhi 89(5): 355-356
Liberski, P.P.; Bratosiewicz, J.; WaliÅ›, A.; Kordek, R.; Jeffrey, M.; Brown, P. 2001: A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited Folia neuropathologica 39(4): 217-235
Prásil, P.; Buchta, V.; Paterová, P.; Hanovcová, I. 2010: Penetration of ceftriaxone into the cerebrospinal fluid and its relationship to inflammatory markers during bacterial meningitis Klinicka Mikrobiologie a Infekcni Lekarstvi 16(2): 64-72
Chang, P.-J.; Sung, Y.-H.; Tsai, Y.-C.; Fang, S.-Y.; Chen, H.-H. 2002: Continuous cerebrospinal fluid drainage using a lumbar subarachnoid catheter for cerebrospinal fluid rhinorrhea after functional endoscopic sinus surgery Acta Anaesthesiologica Sinica 40(2): 97-99
Schulz, D.; Rothenhöfer, C. 1979: Anatomical structures, physiology and pathophysiology of cerebrospinal fluid metabolism; a review for an understanding of cerebrospinal fluid findings Fortschritte der Medizin 97(40): 1814-1820
Döbler, K.; Nolte, H. 1990: Do elevated blood and cerebrospinal fluid glucose levels and other factors modify the density of cerebrospinal fluid and the spread of isobaric spinal anesthesia? Regional-Anaesthesie 13(4): 101-107
Kanoh, Y.; Ohara, T.; Akahoshi, T. 2011: Acute Inflammatory Biomarkers in Cerebrospinal Fluid as Indicators of Blood Cerebrospinal Fluid Barrier Damage in Japanese Subjects with Infectious Meningitis Clinical Laboratory 57(1-2): 37-46
Kumasaka, K. 1988: Laboratory testing on cerebrospinal fluid-cytodiagnosis, tumor markers and alkaline phosphatase-binding immunoglobulin Rinsho Byori. Japanese Journal of Clinical Pathology 36(3): 280-286
Oberascher, G. 1988: Cerebrospinal otorrhea--cerebrospinal rhinorrhea. the Salzburg concept of cerebrospinal fluid diagnosis Laryngologie Rhinologie Otologie 67(8): 375-381
Federico, A.; Annunziata, P. 1975: Cerebrospinal fluid immunoglobulins and neurological diseases Acta Neurologica 30(5): 455-456
Kovarík, J.; Votruba, M.; Sakarová, V.; Rouchal, J. 1977: Changes of cerebrospinal-fluid phospholipids in various neurologic diseases Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Supplementum 20(2-3): 259-263
Maciejek, Z.; Lisiewicz, J.; Lutz, W.; Kochanowski, J. 1981: Inositol in the cerebrospinal fluid in various nervous system diseases Neurologia i Neurochirurgia Polska 15(2): 155-159
Cesnak, D.; Králik, M.; Pavkovceková, O.; Tischler, V.; Virgala, J. 1980: Diagnostic value of IgG values in cerebrospinal fluid in diseases of the CNS in children Casopis Lekaru Ceskych 119(29-30): 796
Bachmann-Harildstad, G. 2008: Diagnostic values of beta-2 transferrin and beta-trace protein as markers for cerebrospinal fluid fistula Rhinology 46(2): 82-85
Maruyama, I.; Igata, A. 1979: Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases Rinsho Shinkeigaku 19(8): 481-485
Nakajima, T. 1981: The analysis of various protein in cerebrospinal fluid in optic nerve diseases Nippon Ganka Gakkai Zasshi 85(8): 941-951
Coret, F.; Vílchez, J.J.; Enguídanos, M.J.; López-Arlandis, J.; Fernández-Izquierdo, S. 1989: The presence of oligoclonal bands in the cerebrospinal fluid in various neurologic diseases Revista Clinica Espanola 185(5): 231-234